A new study presented at the European Association for the Study of the Liver in Berlin this month has renewed hopes for a possible cure for the hepatitis C virus (HCV).

The study — conducted by mostly US researchers — showed two new drugs, in combination with standard-of-care hep C treatment, were able to deliver positive results for those suffering chronic hep C who had previously not responded to standard treatment.

In the study, four of 11 patients treated with the two drugs experienced a long-term positive response, without the need for a more toxic drug regime, www.hivandhepatitis.com reports.

The results mean hep C sufferers may avoid the side effects of drugs interferon and ribavirin.

Most side effects of the new direct-acting drugs were said to be moderate.

Researchers said the results show the two new drugs could change the course of hep C treatment in the future.

© Star Observer 2018 | For the latest in lesbian, gay, bisexual, trans* and intersex (LGBTI) news in Australia, be sure to visit starobserver.com.au daily. You can also read our latest magazines or Join us on our Facebook page and Twitter feed.